These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


234 related items for PubMed ID: 30333477

  • 21. Protective effects of progesterone administration on axonal pathology in mice with experimental autoimmune encephalomyelitis.
    Garay L, Gonzalez Deniselle MC, Meyer M, Costa JJ, Lima A, Roig P, De nicola AF.
    Brain Res; 2009 Aug 04; 1283():177-85. PubMed ID: 19497309
    [Abstract] [Full Text] [Related]

  • 22. Contrasting roles for axonal degeneration in an autoimmune versus viral model of multiple sclerosis: When can axonal injury be beneficial?
    Tsunoda I, Tanaka T, Terry EJ, Fujinami RS.
    Am J Pathol; 2007 Jan 04; 170(1):214-26. PubMed ID: 17200195
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. RGMa Participates in the Blood-Brain Barrier Dysfunction Through BMP/BMPR/YAP Signaling in Multiple Sclerosis.
    Zhang L, Tang S, Ma Y, Liu J, Monnier P, Li H, Zhang R, Yu G, Zhang M, Li Y, Feng J, Qin X.
    Front Immunol; 2022 Jan 04; 13():861486. PubMed ID: 35664003
    [Abstract] [Full Text] [Related]

  • 25. Macrophages and neurodegeneration.
    Hendriks JJ, Teunissen CE, de Vries HE, Dijkstra CD.
    Brain Res Brain Res Rev; 2005 Apr 04; 48(2):185-95. PubMed ID: 15850657
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Relationship of acute axonal damage, Wallerian degeneration, and clinical disability in multiple sclerosis.
    Singh S, Dallenga T, Winkler A, Roemer S, Maruschak B, Siebert H, Brück W, Stadelmann C.
    J Neuroinflammation; 2017 Mar 17; 14(1):57. PubMed ID: 28302146
    [Abstract] [Full Text] [Related]

  • 29. Delayed administration of the human anti-RGMa monoclonal antibody elezanumab promotes functional recovery including spontaneous voiding after spinal cord injury in rats.
    Mothe AJ, Coelho M, Huang L, Monnier PP, Cui YF, Mueller BK, Jacobson PB, Tator CH.
    Neurobiol Dis; 2020 Sep 17; 143():104995. PubMed ID: 32590037
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. RGMa regulates CCL5 expression via the BMP receptor in experimental autoimmune encephalomyelitis mice and endothelial cells.
    Tang S, Su B, Tao T, Yan W, Zhang R, Qin X, Feng J.
    Mol Med Rep; 2022 Mar 17; 25(3):. PubMed ID: 35029290
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Axon loss is responsible for chronic neurological deficit following inflammatory demyelination in the rat.
    Papadopoulos D, Pham-Dinh D, Reynolds R.
    Exp Neurol; 2006 Feb 17; 197(2):373-85. PubMed ID: 16337942
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Nerve growth factor prevents demyelination, cell death and progression of the disease in experimental allergic encephalomyelitis.
    Parvaneh Tafreshi A.
    Iran J Allergy Asthma Immunol; 2006 Dec 17; 5(4):177-81. PubMed ID: 17237570
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 12.